Advanced Care Planning (ACP)NCT06616909
Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences
A study testing ACP GAME and acp manual in people with Advanced Care Planning (ACP) and ELDERLY PEOPLE, run by National Taiwan University Hospital at 1 site in Taiwan.
Trial summary
This randomized controlled trial examined whether an advance care planning (ACP) tabletop game ("Walking with Wishes") could improve the consistency of life-sustaining treatment preferences between older adults with lung cancer and their potential surrogates (family members or friends), compared to a standard ACP… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Advanced Care Planning (ACP), ELDERLY PEOPLE, Lung Cancer (NSCLC)
- What is being tested?
- ACP GAME and acp manual
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 124 participants
- Where
- 1 siteTaiwan
- Study dates
- 25 Sep 2024to 30 Apr 2025
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- lung cancer age ≧ 60
- The elderly with lung cancer are conscious and have no severe visual or hearing impairment.
- The potential surrogate was designated by the older adult with lung cancer as the person who may make medical decisions in the future. The potential surrogate must be at least 18 years old.
Who cannot join
- People with severe hearing loss and visual impairment who are unable to communicate in Mandarin and Taiwanese.
- The potential agent is under 18 years old
Trial locations and contacts
1 site in 1 country.
About this study
This randomized controlled trial examined whether an advance care planning (ACP) tabletop game ("Walking with Wishes") could improve the consistency of life-sustaining treatment preferences between older adults with lung cancer and their potential surrogates (family members or friends), compared to a standard ACP manual. Eligible dyads (patient-surrogate pairs) were randomized 1:1 to either the tabletop game intervention or the ACP manual control group. The primary outcome was the absolute gap score on the modified Life Support Preferences Questionnaire (m-LSPQ), measuring the difference between patient and surrogate preferences for five life-sustaining treatments (antibiotics, CPR, surgery, nasogastric tube feeding, and intravenous infusion) across nine health scenarios. Secondary outcomes included state anxiety (STAI-S) for both patients and surrogates. The m-LSPQ was assessed at baseline (T0), 2 weeks (T2), and 6 weeks (T3) post-intervention. The STAI-S was additionally assessed immediately post-intervention (T1) to capture acute emotional responses to the intervention.
- Being tested
- ACP GAME, acp manual
- Medical subject headings
- Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ACP GAMEBehavioural
,Using board games as an activity intervention, a tool for discussion between elderly people with lung cancer and potential agents
acp manualBehavioural
acp manual
| Study group | Role | What they receive |
|---|---|---|
| game ACP module | Experimental | ,Using board games as an activity intervention, a tool for discussion between elderly people with lung cancer and potential agents Receives: Behavioral: ACP GAME |
| ACP Manual | Placebo comparator | Not described Receives: Behavioral: acp manual |
What is being measured
The primary outcome is the main question the study is designed to answer.
Absolute Gap Score on m-LSPQ Total Score Baseline
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate greater preference for receiving life-sustaining treatments.
Patient and surrogate total scores are reported separately. The absolute gap score is calculated within each patient-surrogate dyad as |surrogate total score - patient total score|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Measured: Baseline (T0)
Absolute Gap Score on m-LSPQ Total Score at 2 Weeks
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as |surrogate total score - patient total score|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Measured: 2 weeks post-intervention (T2)
Absolute Gap Score on m-LSPQ Total Score at 6 Weeks
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as |surrogate total score - patient total score|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Measured: 6 weeks post-intervention (T3)
Secondary outcomes (23)
State Anxiety (STAI-S) of Patients (T0)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It includes 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety.
Measured: Baseline (T0)
State Anxiety (STAI-S) of Patients (T1)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for patients at the specified time point.
Measured: Immediately post-intervention (T1)
State Anxiety (STAI-S) of Patients (T2)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for patients at 2 weeks post-intervention.
Measured: 2 weeks post-intervention (T2)
State Anxiety (STAI-S) of Patients (T3)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for patients at 6 weeks post-intervention.
Measured: 6 weeks post-intervention (T3)
State Anxiety (STAI-S ) of Surrogates (T0)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for surrogates at baseline.
Measured: Baseline (T0)
State Anxiety (STAI-S ) of Surrogates (T1)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current state anxiety. It contains 20 items and yields a total score ranging from 20 to 80; higher scores indicate greater anxiety. Scores are reported as mean and standard deviation for surrogates immediately post-intervention.
Measured: immediately post-intervention (T1)
State Anxiety (STAI-S ) of Surrogates (T2)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for surrogates at the specified time point.
Measured: 2 weeks post-intervention (T2)
State Anxiety (STAI-S ) of Surrogates (T3)
The State-Trait Anxiety Inventory-State (STAI-S) assesses current (state) anxiety. It includes 20 items and yields a total score range of 20 to 80; higher scores indicate higher anxiety. Scores are reported as mean (standard deviation) for surrogates at the specified time point.
Measured: 6 weeks post-intervention (T3)
Absolute Gap in Antibiotics Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 (absolutely unwanted) to 5 (absolutely wanted). The antibiotics subscale includes 9 items, with total scores ranging from 9 to 45. Higher scores indicate a greater preference for receiving antibiotics. Patient and surrogate subscale scores are reported separately. For each patient-surrogate dyad, the absolute gap score was calculated as |surrogate score - patient score|. Gap scores range from 0 to 36; smaller scores indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Measured: Baseline (T0)
Absolute Gap in Antibiotics Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 (absolutely unwanted) to 5 (absolutely wanted). The antibiotics subscale includes 9 items, with total scores ranging from 9 to 45. Higher scores indicate a greater preference for receiving antibiotics. Patient and surrogate subscale scores are reported separately. For each patient-surrogate dyad, the absolute gap score was calculated as |surrogate score - patient score|. Gap scores range from 0 to 36; smaller scores indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Measured: 2 weeks post-intervention (T2)
Absolute Gap in Antibiotics Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The antibiotics subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving antibiotics as a life-sustaining treatment. The absolute gap score for antibiotics preference was calculated as |Surrogate antibiotics subscale score - Patient antibiotics subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 6 weeks post-intervention (T3)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate CPR subscale score - Patient CPR subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: Baseline (T0)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate CPR subscale score - Patient CPR subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 2 weeks post-intervention (T2)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The cardiopulmonary resuscitation (CPR) subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving CPR as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate CPR subscale score - Patient CPR subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 6 weeks post-intervention (T3)
Absolute Gap in Surgery Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate surgery subscale score - Patient surgery subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: Baseline (T0)
Absolute Gap in Surgery Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate surgery subscale score - Patient surgery subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 2 weeks post-intervention (T2)
Absolute Gap in Surgery Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The surgery subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving surgery as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate surgery subscale score - Patient surgery subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 6 weeks post-intervention (T3)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: Baseline (T0)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 2 weeks post-intervention (T2)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The nasogastric tube feeding subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving nasogastric tube feeding as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate NG tube feeding subscale score - Patient NG tube feeding subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 6 weeks post-intervention (T3)
Absolute Gap in Intravenous Infusion (IV) Preference (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: Baseline (T0)
Absolute Gap in Intravenous Infusion (IV) Preference (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 2 weeks post-intervention (T2)
Absolute Gap in Intravenous Infusion (IV) Preference (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) assesses preferences for life-sustaining treatments across nine health scenarios using a 5-point Likert scale, ranging from 1 = "absolutely unwanted" to 5 = "absolutely wanted." The intravenous infusion subscale includes 9 items, one for each health scenario. Subscale scores are calculated by summing the 9 item scores, with possible scores ranging from 9 to 45. Higher scores indicate greater preference for receiving intravenous infusion as a life-sustaining treatment. The absolute gap score was calculated as |Surrogate intravenous infusion subscale score - Patient intravenous infusion subscale score|. Scores range from 0 to 36, with smaller values indicating greater patient-surrogate concordance.
Measured: 6 weeks post-intervention (T3)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Sep 2024
- Study start25 Sep 2024
- Primary completion30 Apr 2025
- Study completion30 Apr 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Advanced Care Planning (ACP)Studies of the same condition, open and under way.
- More trials run by National Taiwan University HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 124 participants (actual)
Sponsor and investigators
- Lead sponsor
- National Taiwan University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06616909
- Sponsor's protocol ID
- 202407186RIND
- Status last verified
- Jul 2026
- First submitted
- 23 Sep 2024
- Last updated
- 30 Oct 2026
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Advance Care Planning Impact on the Consistency of Older Adults With Lung Cancer and Their Potential Surrogates Regarding Life-Sustaining Treatment Preferences
- ClinicalTrials.gov ID
- NCT06616909
- Acronym / sponsor ID
- 202407186RIND
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 124 participants (actual)
- Lead sponsor
- National Taiwan University HospitalUniversity, hospital or other
- Study start
- 25 Sep 2024 (actual)
- Primary completion
- 30 Apr 2025 (actual)
- Study completion
- 30 Apr 2025 (actual)
- First posted
- 27 Sep 2024 (actual)
- Results
- Posted 30 Oct 2026
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial examined whether an advance care planning (ACP) tabletop game ("Walking with Wishes") could improve the consistency of life-sustaining treatment preferences between older adults with lung cancer and their potential surrogates (family members or friends), compared to a standard ACP manual. Eligible dyads (patient-surrogate pairs) were randomized 1:1 to either the tabletop game intervention or the ACP manual control group. The primary outcome was the absolute gap score on the modified Life Support Preferences Questionnaire (m-LSPQ), measuring the difference between patient and surrogate preferences for five life-sustaining treatments (antibiotics, CPR, surgery, nasogastric tube feeding, and intravenous infusion) across nine health scenarios. Secondary outcomes included state anxiety (STAI-S) for both patients and surrogates. The m-LSPQ was assessed at baseline (T0), 2 weeks (T2), and 6 weeks (T3) post-intervention. The STAI-S was additionally assessed immediately post-intervention (T1) to capture acute emotional responses to the intervention.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| game ACP module | Experimental | Behavioral: ACP GAME,Using board games as an activity intervention, a tool for discussion between elderly people with lung cancer and potential agents |
| ACP Manual | Placebo comparator | Behavioral: acp manual |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- lung cancer age ≧ 60
- The elderly with lung cancer are conscious and have no severe visual or hearing impairment.
- The potential surrogate was designated by the older adult with lung cancer as the person who may make medical decisions in the future. The potential surrogate must be at least 18 years old.
Key exclusion criteria (2 listed)
- People with severe hearing loss and visual impairment who are unable to communicate in Mandarin and Taiwanese.
- The potential agent is under 18 years old
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ACP GAME,Using board games as an activity intervention, a tool for discussion between elderly people with lung cancer and potential agents | Behavioural | game ACP module |
| acp manualacp manual | Behavioural | ACP Manual |
Primary outcome
Absolute Gap Score on m-LSPQ Total Score Baseline
Time frame: Baseline (T0)
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. The absolute gap score is calculated within each patient-surrogate dyad as |surrogate total score - patient total score|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Absolute Gap Score on m-LSPQ Total Score at 2 Weeks
Time frame: 2 weeks post-intervention (T2)
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as |surrogate total score - patient total score|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
Absolute Gap Score on m-LSPQ Total Score at 6 Weeks
Time frame: 6 weeks post-intervention (T3)
The modified Life Support Preferences Questionnaire (m-LSPQ) contains 45 items rated from 1 (absolutely unwanted) to 5 (absolutely wanted). The total score is calculated by summing all 45 item scores and ranges from 45 to 225; higher scores indicate a greater preference for receiving life-sustaining treatments. Patient and surrogate total scores are reported separately. For each patient-surrogate dyad, the absolute gap score is calculated as |surrogate total score - patient total score|. The absolute gap score ranges from 0 to 180; smaller values indicate greater patient-surrogate concordance, with 0 indicating complete agreement.
23 secondary outcomes
State Anxiety (STAI-S) of Patients (T0)
Time frame: Baseline (T0)
State Anxiety (STAI-S) of Patients (T1)
Time frame: Immediately post-intervention (T1)
State Anxiety (STAI-S) of Patients (T2)
Time frame: 2 weeks post-intervention (T2)
State Anxiety (STAI-S) of Patients (T3)
Time frame: 6 weeks post-intervention (T3)
State Anxiety (STAI-S ) of Surrogates (T0)
Time frame: Baseline (T0)
State Anxiety (STAI-S ) of Surrogates (T1)
Time frame: immediately post-intervention (T1)
State Anxiety (STAI-S ) of Surrogates (T2)
Time frame: 2 weeks post-intervention (T2)
State Anxiety (STAI-S ) of Surrogates (T3)
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Antibiotics Preference (T0)
Time frame: Baseline (T0)
Absolute Gap in Antibiotics Preference (T2)
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Antibiotics Preference (T3)
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T0)
Time frame: Baseline (T0)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T2)
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Cardiopulmonary Resuscitation (CPR) Preference (T3)
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Surgery Preference (T0)
Time frame: Baseline (T0)
Absolute Gap in Surgery Preference (T2)
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Surgery Preference (T3)
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T0)
Time frame: Baseline (T0)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T2)
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Nasogastric Tube Feeding (NG) Preference (T3)
Time frame: 6 weeks post-intervention (T3)
Absolute Gap in Intravenous Infusion (IV) Preference (T0)
Time frame: Baseline (T0)
Absolute Gap in Intravenous Infusion (IV) Preference (T2)
Time frame: 2 weeks post-intervention (T2)
Absolute Gap in Intravenous Infusion (IV) Preference (T3)
Time frame: 6 weeks post-intervention (T3)
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2026.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: Undecided
Related trials for Advanced Care Planning (ACP)
Not yet recruiting
Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses
Death Anxiety, Death Attitude (Implicit/Explicit)
Recruiting
I CAN DO Surgical ACP
Surgical Advanced Care Planning
Recruiting
Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
Advanced Malignant Solid Neoplasm, Malignant Brain Neoplasm
Recruiting
The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease
Leukemia, Multiple Mieloma
Not yet recruiting
Die-logue Program for Community Dwelling Adults: A Randomized Controlled Trial
Death Attitude (Implicit/Explicit), Death Anxiety
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing ACP GAME and acp manual in people with Advanced Care Planning (ACP) and ELDERLY PEOPLE, run by National Taiwan University Hospital at 1 site in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 30 Oct 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Absolute Gap Score on m-LSPQ Total Score Baseline (time frame: Baseline (T0)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2026.